Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$23.83 - $36.44 $34.2 Million - $52.2 Million
-1,433,774 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$32.75 - $40.35 $10.7 Million - $13.1 Million
-325,550 Reduced 18.5%
1,433,774 $51.5 Million
Q1 2019

May 15, 2019

BUY
$35.47 - $54.55 $8.65 Million - $13.3 Million
243,902 Added 16.09%
1,759,324 $65 Million
Q3 2018

Nov 14, 2018

BUY
$41.65 - $51.7 $1.16 Million - $1.44 Million
27,931 Added 1.88%
1,515,422 $71.6 Million
Q2 2018

Aug 14, 2018

BUY
$48.35 - $65.33 $16.5 Million - $22.3 Million
341,294 Added 29.78%
1,487,491 $74 Million
Q1 2018

May 15, 2018

BUY
$38.64 - $57.54 $8.88 Million - $13.2 Million
229,747 Added 25.07%
1,146,197 $57 Million
Q4 2017

Feb 14, 2018

BUY
$27.28 - $43.26 $25 Million - $39.6 Million
916,450
916,450 $34.1 Million

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $271M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.